BioCentury
ARTICLE | Clinical News

Betafectin: Began randomized, double-blind Phase I study in 25 normal individuals to evaluate the effect of increasing doses with or without growth factor suppo

October 23, 1995 7:00 AM UTC

Alpha-Beta Technology Inc. (ABTI), Worcester, Mass. Product: Betafectin, PGG-glucan carbohydrate Indication: Peripheral blood precursor cell mobilization in high dose chemotherapy Status: Began rando...